Chemotherapy-Induced Peripheral Neuropathy : Nursing Implications
Chemotherapy-induced peripheral neuropathy (CIPN) is an unsolved and potentially life-compromising problem for most patients receiving neurotoxic chemotherapy. It manifests with numbness, tingling, and possibly neuropathic pain and motor and autonomic symptoms. This review aims to provide an evidence synthesis that prepares nurses to comprehensively assess, provide supportive care for, and critically evaluate the literature on CIPN. The prevalence, significance, characteristics, mechanisms, and risk factors of CIPN will be discussed, as well as nursing-relevant evidence on the assessment, prevention, and management of CIPN. The importance of critical literature evaluation before clinical implementation to reduce physical and financial harms to patients will also be highlighted.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
---|---|
Enthalten in: |
Journal of infusion nursing : the official publication of the Infusion Nurses Society - 43(2020), 3 vom: 14. Mai, Seite 155-166 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kanzawa-Lee, Grace A [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 15.02.2021 Date Revised 15.02.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1097/NAN.0000000000000368 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM308721039 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM308721039 | ||
003 | DE-627 | ||
005 | 20231225132337.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1097/NAN.0000000000000368 |2 doi | |
028 | 5 | 2 | |a pubmed24n1029.xml |
035 | |a (DE-627)NLM308721039 | ||
035 | |a (NLM)32287170 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kanzawa-Lee, Grace A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Chemotherapy-Induced Peripheral Neuropathy |b Nursing Implications |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.02.2021 | ||
500 | |a Date Revised 15.02.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Chemotherapy-induced peripheral neuropathy (CIPN) is an unsolved and potentially life-compromising problem for most patients receiving neurotoxic chemotherapy. It manifests with numbness, tingling, and possibly neuropathic pain and motor and autonomic symptoms. This review aims to provide an evidence synthesis that prepares nurses to comprehensively assess, provide supportive care for, and critically evaluate the literature on CIPN. The prevalence, significance, characteristics, mechanisms, and risk factors of CIPN will be discussed, as well as nursing-relevant evidence on the assessment, prevention, and management of CIPN. The importance of critical literature evaluation before clinical implementation to reduce physical and financial harms to patients will also be highlighted | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Journal of infusion nursing : the official publication of the Infusion Nurses Society |d 2001 |g 43(2020), 3 vom: 14. Mai, Seite 155-166 |w (DE-627)NLM114066256 |x 1539-0667 |7 nnns |
773 | 1 | 8 | |g volume:43 |g year:2020 |g number:3 |g day:14 |g month:05 |g pages:155-166 |
856 | 4 | 0 | |u http://dx.doi.org/10.1097/NAN.0000000000000368 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 43 |j 2020 |e 3 |b 14 |c 05 |h 155-166 |